In-Silico Design and Evaluation of the Anti-Wolbachia Potential of Boron-Pleuromutilins

Filariasis (Lymphatic filariasis and Onchocerciasis) is a common neglected tropical disease caused by parasitic nematodes called filarial worms, which often host the Wolbachia bacteria. A good treatment approach seeks Wolbachia as a drug target. Here, a computer-aided design of some boron-pleuromut...

Full description

Bibliographic Details
Main Authors: Fabian Audu Ugbe, Gideon Adamu Shallangwa, Adamu Uzairu, Ibrahim Abdulkadir
Format: Article
Language:English
Published: Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya 2023-05-01
Series:Borneo Journal of Pharmacy
Subjects:
Online Access:https://journal.umpr.ac.id/index.php/bjop/article/view/4677
_version_ 1827167093494120448
author Fabian Audu Ugbe
Gideon Adamu Shallangwa
Adamu Uzairu
Ibrahim Abdulkadir
author_facet Fabian Audu Ugbe
Gideon Adamu Shallangwa
Adamu Uzairu
Ibrahim Abdulkadir
author_sort Fabian Audu Ugbe
collection DOAJ
description Filariasis (Lymphatic filariasis and Onchocerciasis) is a common neglected tropical disease caused by parasitic nematodes called filarial worms, which often host the Wolbachia bacteria. A good treatment approach seeks Wolbachia as a drug target. Here, a computer-aided design of some boron-pleuromutilin analogs was conducted using the ligand-based drug design approach while performing molecular docking investigation and pharmacokinetics analyses to evaluate their drug-likeness properties. The newly designed compounds (49a, 49b, and 49c) showed improved inhibitory activities (pEC50) over those of the template and the clinically relevant pleuromutilins (retapamulin and lefamulin) in the order; 49b (pEC50 = 9.0409) > 49c (8.8175) > 49a (8.5930) > template (49) (8.4222) > retapamulin (6.7403) > lefamulin (6.1369). Standard docking performed with OTU deubiquitinase (6W9O) revealed the order of binding energies; 49c (-88.07 kcal/mol) > 49b (-84.26 kcal/mol) > doxycycline (-83.70 kcal/mol) > template (-82.57 kcal/mol) > 49a (-78.43 kcal/mol) > lefamulin (-76.83 kcal/mol) > retapamulin (-76.78 kcal/mol), with the new compounds all showing good pharmacological interactions with the receptor’s amino acids. The new analogs were also predicted to be orally bioavailable with better pharmacokinetic profiles than the template, retapamulin, lefamulin,  and doxycycline having no more than one violation of Lipinski’s ROF. Therefore, the newly designed compounds could be considered potential anti-filarial drug candidates.
first_indexed 2024-03-13T08:46:18Z
format Article
id doaj.art-99da858de5194bceb7e8d1aed0a7b3c6
institution Directory Open Access Journal
issn 2621-4814
language English
last_indexed 2025-03-21T01:58:48Z
publishDate 2023-05-01
publisher Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya
record_format Article
series Borneo Journal of Pharmacy
spelling doaj.art-99da858de5194bceb7e8d1aed0a7b3c62024-08-02T21:17:30ZengInstitute for Researches and Community Services Universitas Muhammadiyah PalangkarayaBorneo Journal of Pharmacy2621-48142023-05-016210.33084/bjop.v6i2.4677In-Silico Design and Evaluation of the Anti-Wolbachia Potential of Boron-PleuromutilinsFabian Audu Ugbe0Gideon Adamu Shallangwa1Adamu Uzairu2Ibrahim Abdulkadir3Ahmadu Bello UniversityAhmadu Bello UniversityAhmadu Bello UniversityAhmadu Bello University Filariasis (Lymphatic filariasis and Onchocerciasis) is a common neglected tropical disease caused by parasitic nematodes called filarial worms, which often host the Wolbachia bacteria. A good treatment approach seeks Wolbachia as a drug target. Here, a computer-aided design of some boron-pleuromutilin analogs was conducted using the ligand-based drug design approach while performing molecular docking investigation and pharmacokinetics analyses to evaluate their drug-likeness properties. The newly designed compounds (49a, 49b, and 49c) showed improved inhibitory activities (pEC50) over those of the template and the clinically relevant pleuromutilins (retapamulin and lefamulin) in the order; 49b (pEC50 = 9.0409) > 49c (8.8175) > 49a (8.5930) > template (49) (8.4222) > retapamulin (6.7403) > lefamulin (6.1369). Standard docking performed with OTU deubiquitinase (6W9O) revealed the order of binding energies; 49c (-88.07 kcal/mol) > 49b (-84.26 kcal/mol) > doxycycline (-83.70 kcal/mol) > template (-82.57 kcal/mol) > 49a (-78.43 kcal/mol) > lefamulin (-76.83 kcal/mol) > retapamulin (-76.78 kcal/mol), with the new compounds all showing good pharmacological interactions with the receptor’s amino acids. The new analogs were also predicted to be orally bioavailable with better pharmacokinetic profiles than the template, retapamulin, lefamulin,  and doxycycline having no more than one violation of Lipinski’s ROF. Therefore, the newly designed compounds could be considered potential anti-filarial drug candidates. https://journal.umpr.ac.id/index.php/bjop/article/view/4677FilariasisWolbachiaBoron-pleuromutilinsMolecular dockingPharmacokinetics
spellingShingle Fabian Audu Ugbe
Gideon Adamu Shallangwa
Adamu Uzairu
Ibrahim Abdulkadir
In-Silico Design and Evaluation of the Anti-Wolbachia Potential of Boron-Pleuromutilins
Borneo Journal of Pharmacy
Filariasis
Wolbachia
Boron-pleuromutilins
Molecular docking
Pharmacokinetics
title In-Silico Design and Evaluation of the Anti-Wolbachia Potential of Boron-Pleuromutilins
title_full In-Silico Design and Evaluation of the Anti-Wolbachia Potential of Boron-Pleuromutilins
title_fullStr In-Silico Design and Evaluation of the Anti-Wolbachia Potential of Boron-Pleuromutilins
title_full_unstemmed In-Silico Design and Evaluation of the Anti-Wolbachia Potential of Boron-Pleuromutilins
title_short In-Silico Design and Evaluation of the Anti-Wolbachia Potential of Boron-Pleuromutilins
title_sort in silico design and evaluation of the anti wolbachia potential of boron pleuromutilins
topic Filariasis
Wolbachia
Boron-pleuromutilins
Molecular docking
Pharmacokinetics
url https://journal.umpr.ac.id/index.php/bjop/article/view/4677
work_keys_str_mv AT fabianauduugbe insilicodesignandevaluationoftheantiwolbachiapotentialofboronpleuromutilins
AT gideonadamushallangwa insilicodesignandevaluationoftheantiwolbachiapotentialofboronpleuromutilins
AT adamuuzairu insilicodesignandevaluationoftheantiwolbachiapotentialofboronpleuromutilins
AT ibrahimabdulkadir insilicodesignandevaluationoftheantiwolbachiapotentialofboronpleuromutilins